Sonoma Pharmaceuticals (SNOA) Treasury Shares (2017 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly Treasury Shares came in at $118000.0 in Q1 2026, up 162.22% year-on-year from $45000.0 in Q1 2025, and up 43.9% quarter-over-quarter from $82000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Treasury Shares (2017 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Treasury Shares history runs 8 years deep, the most recent figure standing at $118000.0 for Q1 2026.
- On a quarterly basis, Treasury Shares rose 162.22% year-over-year to $118000.0 in Q1 2026; TTM through Mar 2026 was $118000.0, a 162.22% increase from a year earlier, with the FY2026 full-year figure at $118000.0, up 162.22% from the prior year.
- Treasury Shares improved to $118000.0 in Q1 2026 per SNOA's latest filing, from $82000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $118000.0 in Q1 2026 and bottomed at $31000.0 in Q2 2023.
- The 3-year median for Treasury Shares is $93750.0 (2025), against an average of $81166.7.
- Biggest YoY gain for Treasury Shares was 162.22% in 2026; the steepest drop was 162.22% in 2026.
- Year by year, Treasury Shares stood at $31000.0 in 2023, then soared by 164.52% to $82000.0 in 2025, then jumped by 43.9% to $118000.0 in 2026.
- Per Business Quant, the three latest SNOA Treasury Shares figures stand at $118000.0 (Q1 2026), $82000.0 (Q4 2025), and $105500.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | 118,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 118,000.00 |
| Mar 31, 2026 | 118,000.00 |
| Dec 31, 2025 | 82,000.00 |
| Dec 31, 2025 | 82,000.00 |
| Sep 30, 2025 | 105,500.00 |
| Sep 30, 2025 | 105,500.00 |
| Jun 30, 2025 | 105,500.00 |
| Jun 30, 2025 | 105,500.00 |
| Mar 31, 2025 | 45,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Jun 30, 2021 | 833,000.00 |
| Jun 30, 2021 | 833,000.00 |
| Mar 31, 2021 | 833.00 |
| Mar 31, 2021 | 833.00 |
| Dec 31, 2020 | 833.00 |
| Dec 31, 2020 | 833.00 |
| Sep 30, 2020 | 833.00 |
| Sep 30, 2020 | 833.00 |